Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry Rème

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Bioinformatics (Oxford, England)|March 16, 2013
Modeling risk stratification in human cancerThierry Rème, Dirk Hose, Charles Theillet, et al.
Cloning and Stem Cells|September 16, 2009
Transcriptomic analysis identifies Foxo3A as a novel transcription factor regulating mesenchymal stem cell chrondrogenic differentiationFarida Djouad, Claire Bony, François Canovas, et al.
Plos Computational Biology|January 31, 2015
GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cellsAlboukadel Kassambara, Thierry Rème, Michel Jourdan, et al.
Cytometry. Part B, Clinical Cytometry|September 3, 2017
Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometryElina Alaterre, Sébastien Raimbault, Jean-Michel Garcia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Plos One|May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsAlboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Molecular Cancer Therapeutics|October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitorsJérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One|August 4, 2012
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myelomaAlboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
BMC Bioinformatics|January 15, 2008
A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experimentsThierry Rème, Dirk Hose, John De Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2011
Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routineTobias Meissner, Anja Seckinger, Thierry Rème, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Bioinformatics (Oxford, England)|March 16, 2013
Modeling risk stratification in human cancerThierry Rème, Dirk Hose, Charles Theillet, et al.
Cloning and Stem Cells|September 16, 2009
Transcriptomic analysis identifies Foxo3A as a novel transcription factor regulating mesenchymal stem cell chrondrogenic differentiationFarida Djouad, Claire Bony, François Canovas, et al.
Plos Computational Biology|January 31, 2015
GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cellsAlboukadel Kassambara, Thierry Rème, Michel Jourdan, et al.
Cytometry. Part B, Clinical Cytometry|September 3, 2017
Automated and simplified identification of normal and abnormal plasma cells in Multiple Myeloma by flow cytometryElina Alaterre, Sébastien Raimbault, Jean-Michel Garcia, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2009
Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myelomaMaud Condomines, Dirk Hose, Thierry Rème, et al.
Plos One|May 7, 2013
Inhibition of DEPDC1A, a bad prognostic marker in multiple myeloma, delays growth and induces mature plasma cell markers in malignant plasma cellsAlboukadel Kassambara, Matthieu Schoenhals, Jérôme Moreaux, et al.
Molecular Cancer Therapeutics|October 23, 2012
Development of gene expression-based score to predict sensitivity of multiple myeloma cells to DNA methylation inhibitorsJérôme Moreaux, Thierry Rème, Wim Leonard, et al.
Plos One|August 4, 2012
Identification of pluripotent and adult stem cell genes unrelated to cell cycle and associated with poor prognosis in multiple myelomaAlboukadel Kassambara, Dirk Hose, Jérôme Moreaux, et al.
BMC Bioinformatics|January 15, 2008
A new method for class prediction based on signed-rank algorithms applied to Affymetrix microarray experimentsThierry Rème, Dirk Hose, John De Vos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2011
Gene expression profiling in multiple myeloma--reporting of entities, risk, and targets in clinical routineTobias Meissner, Anja Seckinger, Thierry Rème, et al.
Pageof 4